EMYRIA LIMITED

4.65%

4.5¢

Market Cap $26.90M

Healthcare Biotechnology

Emyria Limited is an Australia-based early-stage drug development company. The Company is... Emyria Limited is an Australia-based early-stage drug development company. The Company is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises MDMA analogue drug development and commercialization of novel serotonin-releasing agents. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like assisted therapy for post-traumatic stress disorder (PTSD) and assisted therapy for treatment-resistant depression. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyria’s Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Latest Threads

Tag

Subject

EMD

Ann: Emyria Commences National Expansion with Avive in Brisbane

10:42

11K

10:42

Last post M Sugar

11K

EMD

general talk

6 7 8

09:21

445

174K

09:21

Last post RockstarJones

445

174K

EMD

Legal questions on buyback

06/08/25

212

06/08/25

Last post MirCat

212

EMD

Flushing of dregs holder’s

06/08/25

2.9K

06/08/25

Last post MirCat

2.9K

EMD

Emyria Advances kicks off National Rollout with Avive Health Agreement

29/07/25

202

29/07/25

Last post ASX Insights

202

EMD

Chart - EMD

29/07/25

28K

29/07/25

Last post ectoplasm

28K

EMD

Ann: June 2025 Quarterly Activities Report and Appendix 4C

28/07/25

1.3K

28/07/25

Last post zippydoodaa

1.3K

EMD

Ann: EMD Presents Medibank Deal to US Psychedelic Conference

27/07/25

7.9K

27/07/25

Last post CRUSTY1981

7.9K

See All Discussions

Timeline

Emyria Commences National Expansion with Avive in Brisbane
29 Jul 08:28	Share

June 2025 Quarterly Activities Report and Appendix 4C
28 Jul 09:55	Share

Update - Proposed issue of securities - EMD
25 Jul 17:49	Share

Update on Bonus Loyalty Options Offer
25 Jul 17:36	Share

Less than Marketable Parcel Sale Facility
18 Jul 10:50	Share

Letter to Shareholders - Notice of General Meeting
18 Jul 10:42	Share

Notice of General Meeting/Proxy Form
18 Jul 10:42	Share

Ceasing to be a substantial holder
30 Jun 08:22	Share

Section 708A(5)(e) Notice
26 Jun 11:07	Share

Application for quotation of securities - EMD
26 Jun 11:04	Share

EMD Presents Medibank Deal to US Psychedelic Conference
20 Jun 09:41	Share

Proposed issue of securities - EMD
18 Jun 09:44	Share

Proposed issue of securities - EMD
18 Jun 09:44	Share

Trading Halt
16 Jun 09:48	Share

PTSD Gains Sustained at 6m Follow-Up, MOU Signed with ANU
28 May 08:38	Share

Ceasing to be a substantial holder
19 May 19:26	Share

Notification of cessation of securities - EMD
14 May 08:17	Share

March 2025 Quarterly Activities Report and Appendix 4C
29 Apr 09:33	Share

Emyria Opens New Empax Centre to Meet Demand and Payer Needs
14 Apr 08:22	Share

Change of Director's Interest Notice - M. Winlo
09 Apr 09:24	Share

Section 708A(5)(e) Notice
31 Mar 17:51	Share

Becoming a substantial holder
31 Mar 17:50	Share

Change of Director's Interest Notice x 2
31 Mar 17:40	Share

Notification regarding unquoted securities - EMD
31 Mar 17:31	Share

Application for quotation of securities - EMD
31 Mar 17:16	Share

Results of Meeting
19 Mar 19:25	Share

Section 708A(5)(e) Notice
05 Mar 10:06	Share

Notification regarding unquoted securities - EMD
05 Mar 10:03	Share

Application for quotation of securities - EMD
05 Mar 09:57	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.5¢		Change 0.002(4.65%)		Mkt cap ! $26.90M

Open	High	Low	Value	Volume
4.4¢	4.5¢	4.4¢	$29.77K	669.4K

Buyers (Bids)

No.	Vol.	Price($)
7	478701	4.3¢

Sellers (Offers)

Price($)	Vol.	No.
4.5¢	84912	3

View Market Depth

No.	Vol.	Price($)
7	478701	0.043
3	420084	0.042
7	573333	0.041
9	540946	0.040
4	195172	0.039

Price($)	Vol.	No.
0.045	84912	3
0.046	140994	3
0.047	653000	3
0.048	235649	3
0.049	310853	5

Last trade - 13.20pm 07/08/2025 (20 minute delay)


Last 4.5¢		Change 0.002 ( 2.27 %)
Open	High	Low	Volume
4.5¢	4.5¢	4.4¢	120916
Last updated 13.40pm 07/08/2025 ?

EMD (ASX) Chart

EMYRIA LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Emyria (ASX:EMD) recruits first patient in MDMA-assisted therapy trial for PTSD

10 Jul 2023 12:47 (AEST)

Emyria (ASX:EMD) pockets more than $2m R&D tax refund

12 Jan 2023 10:34 (AEDT)

Latest Articles

Emyria Advances kicks off National Rollout with Avive Health Agreement

Clinical-stage biotech and mental health innovator Emyria Limited (ASX:EMD) has fired up its national expansion strategy by signing a landmark agreement with Avive Health, a growing private hospital operator, to establish its first Empax clinic in Queensland.Under the agreement, Emyria will integ...

Emyria opens second Empax centre in Perth to meet mental health demand

Emyria Ltd has launched a second Empax clinic in Western Australia, aiming to support patients with depression and PTSD

Emyria to plug $2.5M into depression treatment program at Empax Centre

Emyria Ltd has rolled out a Placement to raise more than $2M to expand mental health treatments at its Leederville centre

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News